Your browser is no longer supported. Please, upgrade your browser.
Settings
GSK GlaxoSmithKline plc daily Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E11.02 EPS (ttm)3.45 Insider Own0.20% Shs Outstand2.49B Perf Week-3.23%
Market Cap95.75B Forward P/E12.51 EPS next Y3.04 Insider Trans0.00% Shs Float2.48B Perf Month-5.50%
Income8.66B PEG3.06 EPS next Q0.87 Inst Own11.90% Short Float0.40% Perf Quarter-8.63%
Sales45.40B P/S2.11 EPS this Y31.60% Inst Trans-4.80% Short Ratio3.51 Perf Half Y11.76%
Book/sh7.09 P/B5.36 EPS next Y1.00% ROA8.00% Target Price48.67 Perf Year-9.35%
Cash/sh4.25 P/C8.94 EPS next 5Y3.60% ROE53.60% 52W Range31.43 - 48.25 Perf YTD-19.13%
Dividend1.89 P/FCF16.25 EPS past 5Y10.30% ROI14.30% 52W High-20.46% Beta0.63
Dividend %4.97% Quick Ratio0.70 Sales past 5Y8.00% Gross Margin68.00% 52W Low22.11% ATR0.68
Employees99437 Current Ratio1.00 Sales Q/Q-2.40% Oper. Margin25.50% RSI (14)40.20 Volatility1.39% 1.42%
OptionableYes Debt/Eq2.33 EPS Q/Q133.30% Profit Margin19.10% Rel Volume1.33 Prev Close38.00
ShortableYes LT Debt/Eq1.89 Earnings- Payout10.90% Avg Volume2.84M Price38.38
Recom2.00 SMA20-2.21% SMA50-4.75% SMA200-8.21% Volume511,254 Change1.00%
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-23-20 08:00AM  
Sep-22-20 05:19PM  
12:53PM  
12:09PM  
Sep-21-20 11:53AM  
07:14AM  
05:35AM  
Sep-18-20 05:50PM  
03:57PM  
12:11PM  
11:12AM  
05:27AM  
Sep-17-20 05:48PM  
05:02PM  
04:54PM  
Sep-16-20 02:04PM  
10:33AM  
07:33AM  
Sep-15-20 04:23PM  
01:56PM  
06:30AM  
Sep-14-20 04:39PM  
07:00AM  
Sep-13-20 02:43PM  
Sep-11-20 11:47AM  
10:19AM  
10:00AM  
09:14AM  
Sep-10-20 11:06AM  
07:20AM  
05:15AM  
Sep-09-20 06:45PM  
06:33PM  
11:50AM  
10:17AM  
09:18AM  
09:00AM  
Sep-08-20 04:39PM  
01:58PM  
12:45PM  
12:05PM  
11:39AM  
10:39AM  
10:33AM  
09:11AM  
06:44AM  
06:30AM  
06:30AM  
Sep-04-20 09:25AM  
07:15AM  
Sep-03-20 04:12PM  
03:31PM  
03:14PM  
03:12PM  
12:57PM  
12:46PM  
10:17AM  
09:41AM  
09:37AM  
09:19AM  
07:59AM  
07:55AM  
07:00AM  
05:26AM  
03:02AM  
01:00AM  
Sep-01-20 06:57PM  
06:05PM  
09:39AM  
09:09AM  
08:32AM  
Aug-31-20 04:30PM  
03:39PM  
03:17PM  
03:11PM  
12:45PM  
09:54AM  
08:50AM  
08:04AM  
08:00AM  
08:00AM  
Aug-28-20 10:42PM  
01:51PM  
11:52AM  
07:59AM  
Aug-27-20 05:12PM  
12:23PM  
07:07AM  
Aug-26-20 02:41PM  
03:54AM  
Aug-24-20 08:30AM  
Aug-21-20 11:50AM  
Aug-20-20 01:50PM  
11:21AM  
Aug-19-20 04:48PM  
Aug-17-20 10:38AM  
07:00AM  
Aug-16-20 07:54PM  
10:19AM  
Aug-15-20 07:11AM  
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCDirectorJul 21Buy18.00361,1116,499,9982,248,304Jul 22 04:18 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerOct 18Buy28.00357,1429,999,9762,982,855Oct 22 05:36 PM